Skip to main content

Peer Review reports

From: Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP)

Original Submission
24 Jun 2022 Submitted Original manuscript
27 Jun 2022 Author responded Author comments - Moza Al-Hail
6 Aug 2022 Author responded Author comments - Moza Al-Hail
Resubmission - Version 2
27 Jun 2022 Submitted Manuscript version 2
13 Oct 2022 Reviewed Reviewer Report - Alexandra Chambers
26 Oct 2022 Reviewed Reviewer Report - Bengt Jonsson
12 Nov 2022 Author responded Author comments - Moza Al-Hail
Resubmission - Version 3
12 Nov 2022 Submitted Manuscript version 3
14 Nov 2022 Author responded Author comments - Moza Al-Hail
Resubmission - Version 4
14 Nov 2022 Submitted Manuscript version 4
16 Nov 2022 Author responded Author comments - Moza Al-Hail
Resubmission - Version 5
16 Nov 2022 Submitted Manuscript version 5
20 Nov 2022 Author responded Author comments - Moza Al-Hail
Resubmission - Version 6
20 Nov 2022 Submitted Manuscript version 6
Publishing
16 Dec 2022 Editorially accepted
6 Jan 2023 Article published 10.1186/s12913-022-08981-5

You can find further information about peer review here.

Back to article page